AIMT Forecast and Technical Stock AnalysisSell candidate since 2019-07-10 Loss -7.79%
Aimmune Therapeutics gained 1.38% in the last trading day ( Friday, 19th Jul 2019 ), rising from $18.09 to $18.34 During day the stock fluctuated 3.64% from a day low at $17.86 to a day high of $18.51. The price has been going up and down for this period, and there has been a -11.74% loss for the last 2 weeks. Volume fell in the last day by -316 397 shares, and in total, 492 648 shares bought and sold for approximately $9.04 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the AIMT stock price was $21.51 and low was $16.95.
- 90 day high was $22.15 and low was $16.95.
- 52 week high for the Aimmune Therapeutics - $36.12 and low - $16.95.
Aimmune Therapeutics lies in the lower of a wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $18.08 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.07% during the next 3 months and, with 90% probability hold a price between $17.34 and $20.45 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday July 18, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aimmune Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $18.67 and $19.91. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 30 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
Aimmune Therapeutics finds support from accumulated volume at $18.09.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.65 between high and low, or 3.64%. For the last week, the stock has had a daily average volatility of 3.55%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.55 %Average volatility
Very Low Low Medium High Very High
Aimmune Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|AIMT $18.34 ($0.25 1.38%)|
AIMT is up $0.25 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AIMT based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AIMT analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now